Technology
Health
Biotechnology

Catalyst Biosciences

$8.27
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.18 (-2.13%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CBIO and other stocks, options, ETFs, and crypto commission-free!

About CBIO

Catalyst Biosciences, Inc. Common Stock, also called Catalyst Biosciences, is a clinical-stage biopharmaceutical company, which engages in the development of novel medicines to address serious medical conditions. Read More Its pipeline includes hemostasis such as Factor VIIa marzeptacog alfa, Factor IX dalcinonacog alfa, and Factor Xa; and anti-complement. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.

Employees
21
Headquarters
South San Francisco, California
Founded
2015
Market Cap
99.03M
Price-Earnings Ratio
Dividend Yield
Average Volume
334.43K
High Today
$8.55
Low Today
$8.26
Open Price
$8.48
Volume
114.16K
52 Week High
$11.44
52 Week Low
$6.20

Collections

Technology
Health
Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
2015 IPO
US

CBIO Earnings

-$1.53
-$1.20
-$0.87
-$0.54
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Aug 1, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.